Summary
Taesung is entering a different phase of its equipment cycle.
On October 6, the company disclosed a KRW 6.89 billion contract to supply machinery for FC-BGA production.
The contract equals 18.2% of Taesung’s 2025 consolidated revenue and runs through June 25, 2027.
But one order is not the investment thesis.
The broader operating picture has already changed.
H1 2026 revenue reached KRW 50.4 billion, 33% above the KRW 37.9 billion generated during all of 2025.
Operating profit returned to KRW 2.2 billion.
Taesung also completed a new Cheonan factory that expands production capacity by roughly six to seven times versus its previous base.
By early September, the company said cumulative 2026 orders had surpassed approximately KRW 220 billion.
That number is not the same as regulatory backlog, and it should not be treated as guaranteed revenue.
It does, however, show the scale of the order cycle Taesung is now trying to execute.
The investment question has therefore moved forward.
Can FC-BGA and advanced-substrate demand keep Taesung’s larger factory utilized long enough to create durable earnings?
Key Takeaways
- ✓ Taesung signed a KRW 6.89 billion FC-BGA equipment contract, equivalent to 18.2% of 2025 consolidated revenue.
- ✓ H1 2026 revenue reached KRW 50.4 billion, already exceeding full-year 2025 revenue by 33%.
- ✓ Q2 operating margin recovered to approximately 10.2%, showing the operating leverage available when equipment deliveries accelerate.
- ✓ The new Cheonan factory expands production capacity by roughly six to seven times.
- ✓ Company-reported cumulative orders surpassed approximately KRW 220 billion by early September, but this figure should not be treated as confirmed revenue or a regulatory backlog disclosure.
- ✓ - Glass-substrate equipment is moving from development toward customer qualification, but commercial orders remain the key missing proof point.
- ✓ - With no current three-month earnings or target-price consensus, the stock is being valued primarily on future execution rather than established earnings.
What Happened
Taesung disclosed a KRW 6.89 billion contract on October 6 to supply machinery used in FC-BGA production.
The contract was signed on October 2 and is scheduled to run through June 25, 2027.
The amount represents 18.2% of Taesung’s 2025 consolidated revenue of KRW 37.9 billion.
The customer remains undisclosed for confidentiality reasons.
The payment structure is important.
Thirty percent is payable as an advance.
Another 40% is payable after the equipment is delivered to the customer.
The final 30% is payable after installation is completed and mass-production capability is confirmed.
That creates a clear execution chain:
Order
→ Equipment Production
→ Delivery
→ Installation
→ Mass-Production Qualification
→ Final Payment
A signed order is therefore not equivalent to completed economics.
The contract also appears to extend an existing relationship.
Taesung disclosed that it has executed the same type of contract with the customer during the previous three years.
A separate July contract for KRW 4.31 billion of PCB automation equipment in Vietnam disclosed a customer with the same 2025 revenue figure of KRW 21.896603 trillion and the same broad business description.
That disclosed revenue figure matches LG Innotek’s published 2025 consolidated sales.
The profile is therefore consistent with LG Innotek.
It is not confirmation.
Taesung has not publicly identified the counterparty.
The more important confirmed fact is that a large electronics-components customer is continuing to place equipment orders with Taesung across multiple projects.
Why It Matters
Taesung’s historical earnings have been highly cyclical.
Revenue fell to KRW 33.3 billion in 2023, rebounded to KRW 59.2 billion in 2024 and declined again to KRW 37.9 billion in 2025.
Operating profit followed the same pattern.
The company moved from a KRW 0.7 billion operating loss in 2023 to KRW 6.0 billion of profit in 2024, then back to a KRW 2.5 billion loss in 2025.
That is typical of an equipment supplier whose earnings depend on customer capex timing.
2026 is beginning to look different.
H1 revenue reached KRW 50.4 billion.
That already exceeded full-year 2025 sales.
Operating profit reached KRW 2.2 billion.
The quarterly progression was stronger.
Q1 remained loss-making.
Q2 revenue rose to approximately KRW 30.5 billion and operating profit to approximately KRW 3.1 billion.
Operating margin reached about 10.2%.
The question is whether that recovery represents another short equipment cycle or a structurally larger earnings base.
Three things have changed.
Orders are larger.
Production capacity is much larger.
And customer investment is moving toward more complex advanced substrates.
By early September, Taesung said cumulative orders had surpassed approximately KRW 220 billion.
That compares with only KRW 37.9 billion of 2025 revenue.
The comparison is powerful, but it needs discipline.
Orders can span multiple delivery periods.
Not all orders convert into revenue in the same year.
The figure covers Taesung’s broader equipment business rather than only the October FC-BGA contract.
The relevant question is therefore not the headline size of the order pipeline.
It is the conversion rate from orders into accepted equipment and recognized earnings.
Taesung’s October contract is better viewed as confirmation than as a standalone thesis.
AI and high-performance computing are increasing the complexity of semiconductor packaging.
That is pushing substrate manufacturers toward larger formats, higher layer counts and more demanding process control.
Taesung sits upstream from that investment cycle.
The earnings chain is:
AI / HPC Compute Demand
→ Advanced Substrate Investment
→ Equipment Orders
→ Taesung Production
→ Delivery & Qualification
→ Revenue
→ Factory Utilization
→ Margin
The first half of that chain is increasingly visible.
The second half remains the investment test.
This distinction matters because Taesung has already committed the capital.
In 2025, the company raised KRW 90.45 billion through a rights offering.
KRW 84 billion was allocated to the construction of the Cheonan factory.
The facility is now operating.
Taesung describes the new production base as roughly six to seven times larger in capacity than its previous facilities.
That removes one constraint.
It creates another.
The company now needs enough high-value orders to use that capacity efficiently.
Capacity is not revenue.
Orders are not revenue.
Revenue is not automatically margin.
For Taesung, the next phase is about converting all three.